Regulon

Regulon: R-1633

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
150.86237610Pr-111Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
51230 ENSG00000025293 PHF20 Q9BVI0
9371 ENSG00000101350 KIF3B O15066
22930 ENSG00000115839 RAB3GAP1 Q15042
6310 ENSG00000124788 ATXN1 P54253
23352 ENSG00000127481 UBR4 Q5T4S7
23067 ENSG00000139718 SETD1B Q9UPS6
3480 ENSG00000140443 IGF1R P08069
54877 ENSG00000141664 ZCCHC2 Q9C0B9
115 ENSG00000162104 ADCY9 O60503
54765 ENSG00000166326 TRIM44 Q96DX7
8509 ENSG00000166507 NDST2 P52849
84669 ENSG00000170832 USP32 Q8NFA0
9612 ENSG00000196498 NCOR2 Q9Y618
25829 ENSG00000198792 TMEM184B F2Z397
2869 ENSG00000198873 GRK5 P34947

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
FIGITUMUMABIGF1RAntibodyANTAGONISTInsulin-like growth factor I receptor antagonist30
TEPROTUMUMABIGF1RAntibodyANTAGONISTInsulin-like growth factor I receptor antagonist40
GANITUMABIGF1RAntibodyANTAGONISTInsulin-like growth factor I receptor antagonist30
LINSITINIBIGF1RSmall moleculeINHIBITORInsulin receptor inhibitor30
ISTIRATUMABERBB3AntibodyINHIBITORReceptor tyrosine-protein kinase erbB-3 inhibitor20
KW-2450INSRSmall moleculeINHIBITORInsulin-like growth factor I receptor inhibitor20
BIIB-022IGF1RAntibodyINHIBITORInsulin-like growth factor I receptor inhibitor10
CIXUTUMUMABIGF1RAntibodyANTAGONISTInsulin-like growth factor I receptor antagonist20
AXL-1717IGF1RSmall moleculeINHIBITORInsulin-like growth factor I receptor inhibitor21
ROBATUMUMABIGF1RAntibodyANTAGONISTInsulin-like growth factor I receptor antagonist20
MECASERMIN RINFABATEIGF1RProteinAGONISTInsulin-like growth factor I receptor agonist40
PL-225BIGF1RSmall moleculeINHIBITORInsulin-like growth factor I receptor inhibitor10
XL-228ABL1Small moleculeINHIBITORTyrosine-protein kinase ABL inhibitor10
BMS-754807IGF1RSmall moleculeINHIBITORInsulin receptor inhibitor20
AVE-1642IGF1RAntibodyANTAGONISTInsulin-like growth factor I receptor antagonist20
DALOTUZUMABIGF1RAntibodyANTAGONISTInsulin-like growth factor I receptor antagonist20
MECASERMINIGF1RProteinAGONISTInsulin-like growth factor I receptor agonist40
CONTELTINIBPTK2Small moleculeINHIBITORProtein tyrosine kinase 2 beta inhibitor10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1633

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs